The Antipsoriatic Compound Anthralin Influences Bioenergetic Parameters and Redox Properties of Energy Transducing Membranes
- 31 December 1989
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 94 (1) , 71-76
- https://doi.org/10.1111/1523-1747.ep12873369
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferationBritish Journal of Dermatology, 1987
- The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralinJournal of the American Academy of Dermatology, 1987
- Formation of Active Oxygen Species by Dithranol, III Dithranol, Active Oxygen Species and Lipid Peroxidation in vivoArchiv der Pharmazie, 1987
- Anthralin (1,8-Dihydroxyanthrone) Is a Potent Inhibitor of Leukotriene Production and LTB4-ω Oxidation by Human NeutrophilsJournal of Investigative Dermatology, 1986
- Skin toxicity and cellular metabolism: in vitro modelsBritish Journal of Dermatology, 1986
- Transplasma-membrane redox systems in growth and developmentBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1985
- The effect of anthralin (dithranol) on mitochondriaBritish Journal of Dermatology, 1985
- Anthralin: Historical and current perspectivesJournal of the American Academy of Dermatology, 1983
- Calorimetric and manometric measurements on human skin fibroblasts in cultureBritish Journal of Dermatology, 1981
- Mitochondrial Uncoupling Activity as a Possible Base for a Laxative and Antipsoriatic EffectPharmacology, 1980